Brian G Till

10PUBLICATIONS
65CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 14, 2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

|Apr 06, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.

Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek

|May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy.

George Mo, Sang Y Lee, David G Coffey

|Jan 22, 2024
CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype.

Sang Yun Lee, Dong Hoon Lee, Wei Sun

|Sep 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.

Emily C Liang, Aya Albittar, Jennifer J Huang

|Jul 26, 2020
90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma.

Sherilyn A Tuazon, Brenda M Sandmaier, Theodore A Gooley

Pageof 2